REG-Crystal Amber Fund Limited: Issue of equity and total voting rights

Crystal Amber FundAnnouncement

19/03/2018 14:17

6 March 2018

Crystal Amber Fund Limited

(the “Company”)

Issue of equity and total voting rights

Crystal Amber Fund Limited announces that further to the announcement on 5
March 2018 of its interim results for the six months ended 31 December 2017
and the proposed issue of 125,000 ordinary shares of £0.01 each (“Ordinary
Shares”) to five charities, application has been made to the London Stock
Exchange for 125,000 Ordinary Shares to be admitted to trading on AIM
("Admission").  It is anticipated that Admission will occur on 9 March 2018.

Total Voting Rights

Following Admission, the issued share capital of the Company will comprise
99,124,762 Ordinary Shares. The Company holds 1,473,982 Ordinary Shares in
treasury. Therefore, the total number of voting rights in the Company will be
97,650,780. The voting rights figure may be used by shareholders as the
denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
Company, under the Disclosure Guidance and Transparency Rules.

For further enquiries please contact:

 Crystal Amber Fund Limited                                                
 Christopher Waldron (Chairman)                        Tel: 01481 742 742  
                                                                           
 Allenby Capital Limited - Nominated Adviser                               
 David Worlidge/Liz Kirchner                           Tel: 020 3328 5656  
                                                                           
 Winterflood Investment Trusts - Broker                                    
 Joe Winkley/Neil Langford                             Tel: 020 3100 0160  
                                                                           
 Crystal Amber Advisers (UK) LLP - Investment Adviser                      
 Richard Bernstein                                     Tel: 020 7478 9080  



Copyright (c) 2018 PR Newswire Association,LLC. All Rights Reserved